MedPath

BreEStim and tDCS for Neuropathic Pain Management - Healthy Subjects

Not Applicable
Completed
Conditions
Pain Management
Interventions
Device: BreEStim
Device: tDCS active
Device: tDCS sham
Registration Number
NCT03302780
Lead Sponsor
The University of Texas Health Science Center, Houston
Brief Summary

This study looks at the effect of combined breathing-controlled electrical stimulation (BreEStim) and transcranial direct current stimulation (tDCS) on neuropathic pain after spinal cord injury, amputation, or brain injury. The hypothesis is that a single session of combined BreEStim and tDCS will produce an additive analgesic effect. This record covers the study in a population of healthy volunteers. Note that this study will also enroll spinal cord injury patients, brain injury patients, and amputation patients and that this study as applied to these other populations will be covered in separate ClinicalTrials.gov records.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
6
Inclusion Criteria
  • between 18 and 75 years
  • male and female subjects
  • healthy subjects (i.e., no recent injuries or pain)
Exclusion Criteria
  • recent injuries or pain
  • have a pacemaker, or other metal and/or implanted devices
  • have amputation in their arm(s)
  • have spinal cord injury (SCI) involving impairment of arms
  • have cognitive impairment from brain injury or are not able to follow commands, or to give consent
  • have asthma or other pulmonary disease
  • are not medically stable
  • have preexisting psychiatric disorders
  • alcohol or drug abuse
  • have a history of seizures/Epilepsy, or taking benzodiazepines, anticonvulsants, and antidepressants.
  • Mini-mental state examination (MMSE), a brief 30-point questionnaire test that is commonly used in the literature, will be used to screen for cognitive impairment. A brain injury patient with a score of 24 or lower on MMSE will be excluded.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Sham tDCS and BreEStimBreEStimThis arm includes a 20-min sham tDCS to the current dominant primary motor cortex (M1), followed by a 20-min BreEStim to the median nerve (160 times) transcutaneously on the current dominant side.
active tDCS (M1) and BreEStimtDCS activeThis arm includes a 20-min active tDCS to the current dominant primary motor cortex (M1), followed by a 20-min BreEStim to the median nerve (160 times) transcutaneously on the current dominant side.
Sham tDCS and BreEStimtDCS shamThis arm includes a 20-min sham tDCS to the current dominant primary motor cortex (M1), followed by a 20-min BreEStim to the median nerve (160 times) transcutaneously on the current dominant side.
active tDCS (M1) and BreEStimBreEStimThis arm includes a 20-min active tDCS to the current dominant primary motor cortex (M1), followed by a 20-min BreEStim to the median nerve (160 times) transcutaneously on the current dominant side.
Primary Outcome Measures
NameTimeMethod
Electrical Pain Threshold (EPT)baseline, 10 minutes after tDCS, 10 minutes after BreEstim

Electrical Pain Threshold (EPT) is a type of quantitative sensory test that assesses the lowest electrical current that first evokes a sensation of pricking pain.

Electrical Sensation Threshold (EST)baseline, 10 minutes after tDCS, 10 minutes after BreEstim

Electrical Detection Threshold (EDT) is a type of Quantitative sensory test that assesses the lowest electrical current that first evokes an electrical sensation.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

TIRR

🇺🇸

Houston, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath